Latest news with #RemotePatientMonitoring
Globe and Mail
15-07-2025
- Health
- Globe and Mail
Telehealth Market & Telemedicine Market to Hit USD 180.86 Billion by 2030 with 11.5% CAGR
Browse 548 market data Tables and 65 Figures spread through 500 Pages and in-depth TOC on "Telehealth & Telemedicine Market by Function (Teleconsultation, RPM, Diagnostics & Treatment, Analytics, Administrative), Application (TelelCU, Teleradiology, Telecardiology, Diabetes), End User (Hospital, ASC, Payer), & Region - Global Forecast to 2030 The Telehealth Market & Telemedicine market valued at US$ 83.62 Billion in 2023, is forecasted to grow at a robust CAGR of 11.5%, reaching US$ 94.14 Billion in 2024 and an impressive US$ 180.86 Billion by 2030. The telehealth and telemedicine market are experiencing significant growth primarily driven by the growing geriatric and medically underserved (especially rural) populations, the growing prevalence of chronic conditions, the benefits of telehealth & telemedicine given the current shortage of physicians and care personnel, and advancements in telecommunication technologies, and expansion of remote patient monitoring (RPM) systems. However, regulatory variations across regions, the rise in fraud and abuse within healthcare systems, and behavioural reluctance to adopt new technologies are expected to restrain the market growth during the forecast period. Download PDF Brochure: Browse in-depth TOC on " Telehealth Market & Telemedicine Market" 350 - Tables 50 - Figures 400 - Pages Government initiatives to improve access to healthcare also play a vital role, often providing funding and resources to strengthen telehealth infrastructure, especially in underserved regions. Collaboration between technology firms and healthcare delivery organizations is a very important determinant that will have innovative solutions towards enhancing service delivery and engaging the patient to improved health outcomes. Together, these determinants drive growth in the market and change the face of the healthcare delivery scene to become responsive to patient needs and preferences. By component, the software component is expected to capture the largest share of telehealth & telemedicine market during the forecast period. This would be due to the increasing demand for the digital health solution, which could be used for remote consultations, monitoring, and patient management. The software segment includes different tools and platforms, such as electronic health records (EHR), telemedicine applications, and patient management systems, which are important for providing virtual healthcare services. The product will increase productivity in the hands of healthcare providers through proper communication, real-time tracking of information, and inclusion into other service offerings. Moreover, the cloud-based platform and AI machine learning in application software also support their adoption by enriching the features of diagnosis, treatment plans, and predictive analytics. The healthcare systems that are increasingly adopting digital transformation will be dominated by software solutions in terms of scalability, flexibility, and improved patient outcomes. By Age group, adults segment is dominated the telehealth & telemedicine market. This is due to the steadily rising prevalence rate of chronic diseases and the growing desire for healthcare care among adults. Adults, especially those above age 40, normally require regular and continued monitoring management of conditions for diabetes, high blood pressure as well as cardiovascular-related diseases, which telehealth can be very useful. Telemedicine is easy and convenient for adults to access healthcare services without the need for frequent in-person visits, which is very helpful for people with mobility issues, busy schedules, or limited access to healthcare facilities. Moreover, adults are more likely to embrace technology and use digital health solutions for managing their health, thus contributing to the dominance of the segment in the telehealth and telemedicine market. The major players in the telehealth & telemedicine market with a significant global presence are Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Epic Systems Corporation (US), Oracle (US), Doximity, Inc. (US), Teladoc Health, Inc. (US), American Well (US), Siemens Healthineers AG (Germany), Cisco Systems Inc. (US), Included Health, Inc. (Doctor on Demand, Inc.) (US), AMC Health (US), TeleSpecialists (US), Walgreen Co. (US), Caregility (US), CVS Health (US), EverNorth Health, Inc. (US), Elation (US), Iron Bow Healthcare Solutions (US), and Zoom Communications, Inc. (US), Timedoc Health (US), Cerebral Inc. (US), Kindbody (US), Transcarent (US), and Caresimple, Inc. (US). The market players have adopted strategies such as acquisitions, collaborations, partnerships, mergers, product/service launches & enhancements, and approvals to strengthen their position in the telehealth & telemedicine market. The product and technology innovations have helped the market players expand globally by providing telehealth & telemedicine solutions. These players not only have a comprehensive and diverse product portfolio but also a strong geographic presence. With the increasing adoption of telehealth and telemedicine in various healthcare applications, these players can focus on developing innovative virtual care platforms and adaptive trial design advanced remote patient monitoring solutions, and integrated telemedicine services. These market players offer a diverse range of products and services worldwide. They rely on technological advancements to develop innovative products and services and increase their global footprint. Increasing focus on acquisitions, collaborations, partnerships, mergers, product/service launches and enhancements, and approvals, facilitate the market players to expand their global reach and develop advanced telehealth & telemedicine solutions to sustain their market positions. Koninklijke Philips N.V Koninkliike Philips N.V. is a diversified technology-based company in the healthcare and consumer lifestyle markets. It is one of the leading companies in the healthcare sector with a strong presence in cardiac care, acute care, and home healthcare. The company operates through four segments: Personal Health, Diagnosis & Treatment, Connected Care, and Others. The telehealth and telemedicine services fall under the connected care segment. The connected care segment consists of following business's monitoring, sleep & respiratory care and enterprise informatics. The telehealth solutions are used by providers and patients. The company operates in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In November 2024, Philips has received FDA approval for remote scanning and protocol management features in its Radiology Operations Command Centre (ROCC), allowing radiologists to assist with scans remotely. In January 2023, Philips and Masimo expanded their partnership to enhance telehealth by integrating the Masimo W1 health-tracking watch with Philips' monitoring systems for better patient care at home. Medtronic Medtronic is one of the largest medical technology, services, and solutions companies globally. The company operates through four principal segments, namely, Cardiovascular, Diabetes, Medical Surgical, and Neuroscience. The company extends telehealth solutions across all four segments. Within the Cardiac and Vascular segment, it offers products and services to diagnose, treat, and manage cardiac rhythm disorders and cardiovascular diseases. Medtronic's portfolio encompasses remote monitoring platforms and patient-cantered software through its products and Medtronic Care Management Services. The telehealth solutions offered by the company cover glucose management and cardiac condition management. Medtronic's telehealth device offerings include Bluetooth-enabled and direct-connect peripherals. These devices comprise weight scales, glucometers, blood pressure monitors, pulse oximeters, pedometers, and activity trackers. Medtronic serves its customers in ~160 countries worldwide. The company operates in North America, Latin America, Europe, Asia Pacific, Middle East and Africa and Russia. Epic Systems Corporation Epic Systems is a software development, installation, and support company that also provides consulting services. The company establishes healthcare management software that combines financial and clinical information from inpatient, ambulatory, and payer technology systems. The company's core competency is to provide EHR software solutions. Epic Systems Corporation is integrating Al into telehealth and telemedicine through strategic partnerships with Microsoft and generative Al technologies. Epic aims to improve productivity and patient care in virtual healthcare settings by combining its EHR solutions with Microsoft's Azure OpenAl Service. This encompasses improving workflows, enabling generative Al to compose message responses, and supporting natural language queries. Epic's Al efforts also focus on enhancing self-service reporting tools, maintaining financial integrity, and improving clinical outcomes, all of which will enhance global telehealth and telemedicine systems. It operates its offices in the US, UK, Canada, Denmark, the Netherlands, Norway, Saudi Arabia, the UAE, Finland, Ireland, Australia, Singapore, and Switzerland. For more information, Inquire Now!
Globe and Mail
02-07-2025
- Business
- Globe and Mail
Remote Patient Monitoring (RPM) Market worth $56.94 billion by 2030
"Prominent players in the Remote patient monitoring market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Oracle (US), Boston Scientific Corporation (US), Abbott (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany)" Browse 354 market data Tables and 64 Figures spread through 395 Pages and in-depth TOC on "Remote Patient Monitoring (RPM) Market by Offering (Software, integrated device), Device (Wearable, implants, handheld), Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End user, & Region - Global Forecast to 2030 The global US Remote Patient Monitoring Market, valued at US$14.15 billion in 2024, is forecasted to grow at a robust CAGR of 12.8%, reaching US$29.13 billion by 2030. The growing number of elderly individuals and the increasing demand for cost-effective healthcare solutions are key drivers of the remote patient monitoring (RPM) market in the US. According to the Population Reference Bureau, US population aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, marking a 47% increase. During this period, the share of seniors in the total population is projected to rise from 17% to 23%. For example, US companies such as Boston Scientific Corporation, Abbott, and Dexcom enhance RPM through digital biomarkers and AI-driven analytics. Government initiatives, including Medicare reimbursement for RPM services and the CMS Hospital-at-Home program, further accelerate adoption. Download PDF Brochure: By Based on component, the US remote patient monitoring market has been segmented into devices, software and services. In 2023, device segment is estimated to hold the largest share in the US remote patient monitoring market. Recent innovations in the US remote patient monitoring (RPM) market such as in March 2024, Dexcom (US) receives FDA clearance for Stelo a glucose biosensor. The device is connected to a smartphone for continuous glucose monitoring. Furthermore, the American Hospital Association supports the remote care delivery across state lines. These initiatives collectively aim to enhance patient care through improved access and technology integration in healthcare systems By patients' segment, the fastest growth in the US remote patient monitoring market due to the rising patient awareness, increase in the prevalence of chronic diseases rises, and growing preference for home health care. The advancements in wearable technology and mobile health applications have made it easier for patients to engage with their health data actively. For instance, in August 2023, GE HealthCare (US) received 510(k) clearance from the US FDA for its Portrait Mobile wireless and wearable monitoring solution that provides personalized view of patient vitals. The US RPM market is expanding further due to the rising demand for affordable healthcare solutions, especially as the aging population becomes increasingly comfortable with technology. By Based on indication, the US remote patient monitoring market has been segmented into cardiology, diabetes, oncology, neurology, sleep disorders, wellness improvement, respiratory disorders, mental health, and other indications. The cardiology segment holds the largest share in the US remote patient monitoring market due to the increase in the cardiovascular diseases, and advancements in products that provide real-time cardiac data. According to the American Heart Association, approximately 2,300 people die from cardiovascular diseases (CVDs) each day in the US alone and according to the WHO, every year, CVDs cause 17.9 million deaths worldwide. Further improvements, such as in June 2024, AliveCor, Inc. (US) announced FDA clearance for Kardia 12L ECG system that detect 35 cardiac determinations, including heart attacks, using a reduced lead set. Some of the prominent players in the US remote patient monitoring market includes GE HealthCare (US), Oracle (US), Boston Scientific Corporation (US), VitalConnect (US), Abbott (US), Optum, Inc (US), Blue Spark Technologies (US), Lightbeam (US) and others. For more information, Inquire Now!
Associated Press
30-06-2025
- Health
- Associated Press
CoachCare CEO Testifies Before U.S. House Ways and Means Subcommittee on the Future of Remote Patient Monitoring
Company continues to lead national dialogue on the role of digital health data and access to care in rural and underserved communities 'This hearing reflects the growing recognition that RPM is not just a promising innovation—it's essential infrastructure for modern healthcare.'— Andrew Zengilowski, CEO and Co-Founder WASHINGTON, DC, UNITED STATES, June 30, 2025 / / -- CoachCare, a leading provider of remote care technology and services, today announced that its CEO and Co-Founder, Andrew Zengilowski, testified before the U.S. House of Representatives Committee on Ways and Means, Subcommittee on Health, during a hearing titled 'Health at Your Fingertips: Harnessing the Power of Digital Health Data.' As a founding member of the Remote Monitoring Leadership Council, Zengilowski shared CoachCare's frontline experience delivering high-touch, high-tech care to more than 500,000 patients—many in rural and underserved communities—and outlined specific policy recommendations to modernize Medicare reimbursement for Remote Patient Monitoring (RPM). 'This hearing reflects the growing recognition that RPM is not just a promising innovation—it's essential infrastructure for modern healthcare,' said Zengilowski. 'We're proud to advocate for sustainable, data-driven care models that improve outcomes, reduce costs, and expand access for all patients, regardless of geography.' Championing the Power of Digital Health Data In his testimony, Zengilowski described how CoachCare combines real-time physiologic data with clinical oversight to shift care from episodic to continuous—preventing unnecessary ER visits and enabling patients to better manage chronic conditions from home. He emphasized that RPM empowers patients with visibility into their own health data while enabling providers to act on early warning signs. 'Remote monitoring turns data into action. When we detect a patient's blood pressure spike, we can intervene immediately—not days or weeks later,' said Zengilowski. 'That's the future of healthcare: proactive, personalized, and data-enabled.' A Call for Sustainable Reimbursement Zengilowski also called on Congress to update RPM reimbursement to reflect the full cost and complexity of delivering care today. He cited rising costs for connected devices, information security, and patient engagement—particularly in rural areas where broadband and staffing challenges persist. 'RPM today requires advanced infrastructure and clinical sophistication. We urge lawmakers to align reimbursement with this reality, ensuring continued access for patients and sustainability for the providers who serve them,' Zengilowski said. His recommendations included: --Adjusting Medicare reimbursement to reflect the cost of software, cellular connectivity, and multi-device care plans. --Eliminating geographic payment disparities that disproportionately affect rural and underserved communities. --Supporting innovation in AI and predictive analytics to further drive value and outcomes. Building on Momentum CoachCare's testimony comes on the heels of two major announcements: its acquisition of MD Revolution, a leader in chronic care management and RPM, and its role as a founding member of the Remote Monitoring Leadership Council—solidifying its position at the forefront of remote care innovation and advocacy. 'As we continue to grow, we're also helping shape the policies that determine the future of care,' added Zengilowski. 'We're honored to bring our voice—and the voices of the providers and patients we serve—to Congress.' To read Zengilowski's written testimony, visit: To watch the full hearing, visit: About CoachCare Founded in 2014, CoachCare powers remote care for provider organizations, enabling successful programs in RPM, CCM, PCM RTM, BHI, INR, APCM and more. CoachCare's digital platform includes proprietary software and devices, remote care management services, and robust analytics—helping clients achieve clinical outcomes and financial ROI at scale. Backed by over $100 million in funding and nine strategic acquisitions, CoachCare is one of the most established and fastest-growing companies in remote care. CoachCare Marketing Department CoachCare email us here Visit us on social media: LinkedIn Facebook X Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Yahoo
14-06-2025
- Health
- Yahoo
Dr. Nihar Gala Expands Healthcare Innovations with the Launch of CareIQ and Publishes New Book "The Strength to Endure"
SEAFORD, DE / / June 14, 2025 / Esteemed Delaware-based physician, entrepreneur, and healthcare innovator Dr. Nihar Gala is proud to announce the launch of his latest venture, CareIQ, a forward-thinking Remote Patient Monitoring (RPM) vendor company that brings cutting-edge technology and clinical services directly to healthcare providers and their patients. Building on the success of Alpha Care Medical, his primary care network with four locations across Delaware, Dr. Nihar Gala continues to lead transformative change in modern medicine. CareIQ, officially launched in January, represents a major leap in improving continuity of care beyond traditional clinic visits. This turnkey RPM solution empowers healthcare providers to seamlessly deliver remote care using cellular-enabled monitoring devices, a cloud-based registration platform, a patient-friendly mobile application, and clinical monitoring services that enable early detection and better chronic disease management. "We designed CareIQ to solve real challenges that both patients and providers face in today's evolving healthcare landscape," said Dr. Nihar Gala, Founder and CEO of CareIQ. "Our goal is to close the gaps in care by making remote patient monitoring easier to implement, more effective, and ultimately more accessible for all." Dr. Nihar Gala brings more than a decade of experience to this new venture. After earning his MD from Rutgers University in 2012, he completed his internship and residency in family medicine at the same institution. He later founded Alpha Care Medical in 2017, where he currently serves as CEO. Alpha Care Medical takes an integrative approach to care, offering services in primary care, behavioral health, psychiatry, and addiction treatment, with locations in Seaford, Millsboro, Dover, and Harrington. Dr. Gala's deep understanding of patient needs and healthcare delivery models has helped him identify innovative solutions like CareIQ. With the rise in chronic conditions and increasing demand for remote access to medical services, CareIQ offers providers a complete package to improve patient outcomes while reducing hospital readmissions. Alongside this major business launch, Dr. Nihar Gala has also made his debut as an author with the publication of his new book, "The Strength to Endure," now available on Amazon. The book draws from personal and professional experiences, offering readers insight into resilience, leadership, and overcoming adversity in both life and business. It is a reflection of his passion not only for healthcare but for mentoring and inspiring the next generation. In 2022, Dr. Nihar Gala expanded his philanthropic efforts with the Dr. Nihar Gala Scholarship for American Entrepreneurs, a nonprofit initiative designed to financially support and raise awareness for aspiring business owners across the United States. The scholarship underscores his belief in the power of education and innovation to shape a better future. Fluent in English, Spanish, and Hindi, and born and raised in Delaware, Dr. Gala's personal connection to the community remains at the heart of everything he does. His impeccable record of professionalism and care continues to position him as a trusted leader in healthcare. With the launch of CareIQ and the release of "The Strength to Endure", Dr. Nihar Gala once again proves his unwavering commitment to redefining the healthcare experience while uplifting others through knowledge, innovation, and compassion. Contact Info: Spokesperson: Dr. Nihar GalaOrganization: CareIQWebsite: SOURCE: CareIQ View the original press release on ACCESS Newswire Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12-06-2025
- Health
- Yahoo
Implantable Remote Patient Monitoring Devices Market to Grow 21.7% CAGR by 2029
"Innovation-Driven and Knowledge-Intensive: Implantable Remote Patient Monitoring Devices Seek Flexible, Integrated Solutions Amid Accelerating Market Timelines and Rising Competition" Boston, June 12, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the 'Global Implantable Remote Patient Monitoring Devices Market' is expected to grow from $7.6 billion in 2024 to $20.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 21.7% from 2024 to 2029. The report on the implantable remote patient monitoring (IRPM) device market analyzes market shares by product, indication and end users. It segments the market into device types, such as cardiovascular, brain, gastrointestinal, hematological, respiratory, and musculoskeletal monitoring devices. Indication consists of cardiovascular diseases, brain disorders, and diabetes End users include hospitals, clinics, and home healthcare settings. Additionally, it offers a study of the competitive landscape, regional analysis, consumer insights, and a supply chain analysis, helping stakeholders make informed decisions and identify strategic opportunities. This report is particularly relevant today because implantable remote patient monitoring (IRPM) devices are transforming healthcare by enhancing patient outcomes, lowering healthcare costs, and increasing accessibility. These devices facilitate continuous monitoring of chronic conditions, enabling real-time data collection and analysis, which can lead to early detection of complications and more timely interventions. The factors driving the market's growth include: Chronic Diseases and the Aging Population: The rise in chronic diseases and the global aging population increase the need for continuous health monitoring. Implantable devices help manage these conditions more effectively, reducing hospital visits and improving patient outcomes. Demand for mHealth Applications: mHealth apps are gaining in popularity for their convenience and real-time health data. They enhance implantable devices by providing comprehensive health data, driven by the widespread use of smartphones and rising awareness of the benefits of digital health. Improved Wireless Technologies: Advances in wireless tech, such as 5G, improve the reliability and efficiency of remote patient monitoring. These technologies enable faster data transmission and more stable connections, which are crucial for real-time health monitoring. Request a sample copy of the global market for implantable remote patient monitoring (IRPM) devices report. Report Synopsis Report Metric Details Base year considered 2023 Forecast period considered 2024-2029 Base year market size $6.5 billion Market size forecast $20.3 billion Growth rate CAGR of 21.7% from 2024 to 2029 Segments covered By product, disease indication, end user, and region Regions covered North America, Europe, Asia-Pacific, and the Rest of World (RoW) Market drivers Increasing prevalence of chronic diseases due to an aging population. Growing demand for mHealth applications. Improved wireless communication technologies. Interesting facts: Reducing Hospital Readmissions: Implantable RPM devices can decrease hospital readmissions by up to 30%, which is crucial for managing chronic conditions like heart failure. Innovative Power Sources and AI Integration: Some implantable devices are powered by the human body, eliminating the need for external batteries. Additionally, integrating artificial intelligence (AI) enhances their predictive capabilities, allowing real-time adjustments to patient care. The report addresses the following questions: What is the projected size and growth rate of the global market for implantable remote patient monitoring devices? The global market for implantable remote patient monitoring devices was valued at $6.5 billion in 2023 and is expected to reach $20.3 billion by the end of 2029, at a CAGR of 21.7% from 2024 to 2029. What are the key factors driving the growth of the market? These include the increasing prevalence of chronic diseases due to an aging population, growing demand for mHealth applications, and improved wireless communication technologies. What market segments does the report cover? The global market for implantable remote patient monitoring devices is segmented by product, indication, end user and region. Which indication segment will enjoy market dominance through the forecast period? The cardiovascular diseases segment will have that position. Which region has the largest share of the global market for implantable remote patient monitoring devices? North America holds the largest share of the market. Leading Companies Include: ABBOTT AVERTIX MEDICAL INC. BIOTRONIK BOSTON SCIENTIFIC CORP. CARDIAC RMS DEXCOM INC. EBR SYSTEMS INC. ENDOTRONIX INC. INJECTSENSE INC. IMPULSE DYNAMICS MEDICO S.R.L. MEDTRONIC PROFUSA INC. QURA LLC. VITALCONNECT Navigate Uncertainty with ConfidenceIn times of rapid change and uncertainty, having the right insights can make all the difference. At BCC Research, we are here to support innovation and help you stay ahead. Our custom research reports provide a comprehensive, 360-degree view of your market landscape, giving you the clarity you need to make informed decisions. We believe that timely, expert market intelligence should be accessible to all. That is why, for a limited time, we are offering 30% off the price of any BCC Research report to help more organizations gain access to our latest data and insights. Purchase a copy of the report directly from BCC Research. For further information on any of these reports or to make a purchase, contact info@ About BCC Research BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype. For media inquiries, email press@ or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. CONTACT: BCC Research Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA Email: info@ Phone: +1 781-489-7301Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
